Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Modified ABC: A Home-based Parenting Program for Opioid-dependent Mothers and Their Infants (mABC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03891628
Recruitment Status : Recruiting
First Posted : March 27, 2019
Last Update Posted : June 30, 2020
Sponsor:
Information provided by (Responsible Party):
Mary Dozier, University of Delaware

Brief Summary:
This study will assess the efficacy of the modified Attachment and Biobehavioral Catch-Up Intervention, adapted for use with peripartum mothers receiving medication-assisted treatment for opioid use disorder. The investigators expect that mothers who receive the modified Attachment and Biobehavioral Catch-up Intervention will show more nurturing and sensitive parenting and more adaptive physiological regulation than parents who receive a control intervention. The investigators expect that infants whose mothers receive the modified Attachment and Biobehavioral Catch-up will show better outcomes in attachment, behavior, and physiological regulation compared to infants of parents who receive the control intervention.

Condition or disease Intervention/treatment Phase
Opioid-Related Disorders Parent-Child Relations Infant Development Parenting Behavioral: Modified Attachment and Biobehavioral Catch-up Behavioral: Modified Developmental Education for Families Behavioral: Safe Environment for Every Kid Not Applicable

Detailed Description:

Peripartum mothers will be randomly assigned to receive the modified ABC intervention or the control intervention (modified DEF). Hypotheses relate to parent and child outcomes associated with the intervention.

Hypothesis 1: Compared to mothers who receive the control intervention, mothers who receive the ABC intervention will show more nurturing and sensitive parenting, enhanced neural activity during parenting-relevant tasks, and more normative patterns of DNA methylation, autonomic nervous system activity, and cortisol production.

Hypothesis 2: Compared to infants of mothers who receive the control intervention, infants of mothers who receive the ABC intervention will show more organized and secure attachment patterns, better behavioral regulation during stressors, more advanced social-emotional development, and more normative patterns of DNA methylation, autonomic nervous system activity, and cortisol production.

Hypothesis 3: Enhanced maternal sensitivity will mediate effects of the ABC intervention on improved infant outcomes.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 120 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Modified Attachment and Biobehavioral Catch-Up for Mothers and Their Infants
Actual Study Start Date : August 13, 2018
Estimated Primary Completion Date : March 31, 2025
Estimated Study Completion Date : March 31, 2025

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Parenting

Arm Intervention/treatment
Experimental: Modified ABC and SEEK
Modified Attachment and Biobehavioral Catch-Up (14 session in-home intervention with parents and infants present) and Safe Environment for Every Kid (1 to 2 in-home resource visits)
Behavioral: Modified Attachment and Biobehavioral Catch-up
Intervention targets include enhancing nurturance and following the child's lead, as well as supporting use of kangaroo care, swaddling, and breastfeeding.
Other Name: mABC

Behavioral: Safe Environment for Every Kid
Intervention involves screening for common challenges and providing community resources to address identified needs.
Other Name: SEEK

Active Comparator: Modified DEF and SEEK
Modified Developmental Education for Families (14 session in-home intervention with parents and infants present) and Safe Environment for Every Kid (1 to 2 in-home resource visits)
Behavioral: Modified Developmental Education for Families
Intervention targets include supporting developmental monitoring and parental engagement in activities that promote cognitive and motor development.
Other Name: mDEF

Behavioral: Safe Environment for Every Kid
Intervention involves screening for common challenges and providing community resources to address identified needs.
Other Name: SEEK




Primary Outcome Measures :
  1. Maternal sensitivity [ Time Frame: Pre-intervention (third trimester of gestation or up to one month postpartum) ]
    Maternal sensitivity will be coded observationally from maternal interactions with an infant simulator pre-programmed to coo and then cry. Mothers will be coded for sensitivity, nurturance, intrusiveness, detachment, and positive regard, on 5 point scales from 1-Not at all characteristic to 5-Highly characteristic. Higher scores on sensitivity, nurturance, and positive regard represent more positive parenting, whereas higher scores on nurturance and detachment represent less positive parenting.

  2. Maternal sensitivity [ Time Frame: Infant age 3 months ]
    Maternal sensitivity will be coded observationally from mother-infant play interactions, in which mothers will be given toys and asked to play as they normally would. Mothers will be coded for sensitivity, nurturance, intrusiveness, detachment, and positive regard, on 5 point scales from 1-Not at all characteristic to 5-Highly characteristic. Higher scores on sensitivity, nurturance, and positive regard represent more positive parenting, whereas higher scores on nurturance and detachment represent less positive parenting.

  3. Maternal sensitivity [ Time Frame: Infant age 6 months ]
    Maternal sensitivity will be coded observationally from mother-infant play interactions, in which mothers will be given toys and asked to play as they normally would. Mothers will be coded for sensitivity, nurturance, intrusiveness, detachment, and positive regard, on 5 point scales from 1-Not at all characteristic to 5-Highly characteristic. Higher scores on sensitivity, nurturance, and positive regard represent more positive parenting, whereas higher scores on nurturance and detachment represent less positive parenting.

  4. Maternal sensitivity [ Time Frame: Infant age 12 months ]
    Maternal sensitivity will be coded observationally from mother-infant play interactions, in which mothers will be given toys and asked to play as they normally would. Mothers will be coded for sensitivity, nurturance, intrusiveness, detachment, and positive regard, on 5 point scales from 1-Not at all characteristic to 5-Highly characteristic. Higher scores on sensitivity, nurturance, and positive regard represent more positive parenting, whereas higher scores on nurturance and detachment represent less positive parenting.

  5. Maternal methylation of μ-opioid receptor (OPRM1) gene [ Time Frame: Pre-intervention (third trimester of gestation or up to one month postpartum) ]
    Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.

  6. Maternal methylation of μ-opioid receptor (OPRM1) gene [ Time Frame: Infant age 3 months ]
    Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.

  7. Maternal methylation of μ-opioid receptor (OPRM1) gene [ Time Frame: Infant age 6 months ]
    Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.

  8. Maternal methylation of μ-opioid receptor (OPRM1) gene [ Time Frame: Infant age 12 months ]
    Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.

  9. Maternal methylation of oxytocin receptor (OXTR) gene [ Time Frame: Pre-intervention (third trimester of gestation or up to one month postpartum) ]
    Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.

  10. Maternal methylation of oxytocin receptor (OXTR) gene [ Time Frame: Infant age 3 months ]
    Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.

  11. Maternal methylation of oxytocin receptor (OXTR) gene [ Time Frame: Infant age 6 months ]
    Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.

  12. Maternal methylation of oxytocin receptor (OXTR) gene [ Time Frame: Infant age 12 months ]
    Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.

  13. Infant methylation of μ-opioid receptor (OPRM1) gene [ Time Frame: Infant age 3 months ]
    Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.

  14. Infant methylation of μ-opioid receptor (OPRM1) gene [ Time Frame: Infant age 6 months ]
    Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.

  15. Infant methylation of μ-opioid receptor (OPRM1) gene [ Time Frame: Infant age 12 months ]
    Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.

  16. Infant methylation of oxytocin receptor (OXTR) gene [ Time Frame: Infant age 3 months ]
    Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.

  17. Infant methylation of oxytocin receptor (OXTR) gene [ Time Frame: Infant age 6 months ]
    Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.

  18. Infant methylation of oxytocin receptor (OXTR) gene [ Time Frame: Infant age 12 months ]
    Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.

  19. Maternal neural activity (EEG) - Own child-other child task [ Time Frame: Pre-intervention (third trimester of gestation or up to one month postpartum) ]
    Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing photos of their own infants, familiar infants, and unfamiliar infants.

  20. Maternal neural activity (EEG) - Own child-other child task [ Time Frame: Infant age 12 months ]
    Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing photos of their own infants, familiar infants, and unfamiliar infants.

  21. Maternal neural activity (EEG) - Reward sensitivity task [ Time Frame: Pre-intervention (third trimester of gestation or up to one month postpartum) ]
    Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing images from four categories: opioid-related images, baby pictures, positive images, and neutral images.

  22. Maternal neural activity (EEG) - Reward sensitivity task [ Time Frame: Infant age 12 months ]
    Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing images from four categories: opioid-related images, baby pictures, positive images, and neutral images.

  23. Maternal neural activity (EEG) - Child emotion task [ Time Frame: Pre-intervention (third trimester of gestation or up to one month postpartum) ]
    Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing images of children crying, laughing, and showing neutral expressions.

  24. Maternal neural activity (EEG) - Child emotion task [ Time Frame: Infant age 12 months ]
    Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing images of children crying, laughing, and showing neutral expressions.

  25. Maternal parasympathetic nervous system activity [ Time Frame: Pre-intervention (third trimester of gestation or up to one month postpartum) ]
    Maternal parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.

  26. Maternal sympathetic nervous system activity [ Time Frame: Pre-intervention (third trimester of gestation or up to one month postpartum) ]
    Maternal sympathetic nervous system activity will be assessed using pre-ejection period.

  27. Maternal parasympathetic nervous system activity [ Time Frame: Infant age 3 months ]
    Maternal parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.

  28. Maternal sympathetic nervous system activity [ Time Frame: Infant age 3 months ]
    Maternal sympathetic nervous system activity will be assessed using pre-ejection period.

  29. Maternal parasympathetic nervous system activity [ Time Frame: Infant age 6 months ]
    Maternal parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.

  30. Maternal sympathetic nervous system activity [ Time Frame: Infant age 6 months ]
    Maternal sympathetic nervous system activity will be assessed using pre-ejection period.

  31. Maternal parasympathetic nervous system activity [ Time Frame: Infant age 12 months ]
    Maternal parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.

  32. Maternal sympathetic nervous system activity [ Time Frame: Infant age 12 months ]
    Maternal sympathetic nervous system activity will be assessed using pre-ejection period.

  33. Infant parasympathetic nervous system activity [ Time Frame: Infant age 3 months ]
    Infant parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.

  34. Infant sympathetic nervous system activity [ Time Frame: Infant age 3 months ]
    Infant sympathetic nervous system activity will be assessed using pre-ejection period.

  35. Infant parasympathetic nervous system activity [ Time Frame: Infant age 6 months ]
    Infant parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.

  36. Infant sympathetic nervous system activity [ Time Frame: Infant age 6 months ]
    Infant sympathetic nervous system activity will be assessed using pre-ejection period.

  37. Infant parasympathetic nervous system activity [ Time Frame: Infant age 12 months ]
    Infant parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.

  38. Infant sympathetic nervous system activity [ Time Frame: Infant age 12 months ]
    Infant sympathetic nervous system activity will be assessed using pre-ejection period.

  39. Maternal diurnal cortisol production [ Time Frame: Pre-intervention (third trimester of gestation or up to one month postpartum) ]
    Maternal diurnal cortisol production will be assessed through salivary cortisol levels collected at wake-time and bed-time.

  40. Maternal diurnal cortisol production [ Time Frame: Infant age 12 months ]
    Maternal diurnal cortisol production will be assessed through salivary cortisol levels collected at wake-time and bed-time.

  41. Infant diurnal cortisol production [ Time Frame: Infant age 3 months ]
    Infant diurnal cortisol production will be assessed through salivary cortisol levels collected at wake-time and bed-time.

  42. Infant diurnal cortisol production [ Time Frame: Infant age 6 months ]
    Infant diurnal cortisol production will be assessed through salivary cortisol levels collected at wake-time and bed-time.

  43. Infant diurnal cortisol production [ Time Frame: Infant age 12 months ]
    Infant diurnal cortisol production will be assessed through salivary cortisol levels collected at wake-time and bed-time.

  44. Infant behavioral regulation - Still Face Paradigm [ Time Frame: Infant age 6 months ]
    Behavioral coding of emotion reactivity and regulation will be conducted from video recordings of the Still Face Paradigm, a mild social stressor.

  45. Infant behavioral regulation - Arm Restraint Task [ Time Frame: Infant age 12 months ]
    Behavioral coding of emotion reactivity and regulation will be conducted from video recordings of the Arm Restraint Task, a mild stressor.

  46. Infant attachment [ Time Frame: Infant age 12 months ]
    Infant attachment will be assessed using the Strange Situation.

  47. Infant cognitive development [ Time Frame: Infant age 3 months ]
    Infant cognitive development will be assessed through maternal report on the Ages and Stages Questionnaire.

  48. Infant motor development [ Time Frame: Infant age 3 months ]
    Infant motor development will be assessed through maternal report on the Ages and Stages Questionnaire.

  49. Infant social-emotional development [ Time Frame: Infant age 3 months ]
    Infant social-emotional development will be assessed through maternal report on the Ages and Stages Questionnaire: Social-Emotional.

  50. Infant cognitive development [ Time Frame: Infant age 6 months ]
    Infant cognitive development will be assessed through maternal report on the Ages and Stages Questionnaire.

  51. Infant motor development [ Time Frame: Infant age 6 months ]
    Infant motor development will be assessed through maternal report on the Ages and Stages Questionnaire.

  52. Infant social-emotional development [ Time Frame: Infant age 6 months ]
    Infant social-emotional development will be assessed through maternal report on the Ages and Stages Questionnaire: Social-Emotional.

  53. Infant cognitive development [ Time Frame: Infant age 12 months ]
    Infant cognitive development will be assessed through maternal report on the Ages and Stages Questionnaire.

  54. Infant motor development [ Time Frame: Infant age 12 months ]
    Infant motor development will be assessed through maternal report on the Ages and Stages Questionnaire.

  55. Infant social-emotional development [ Time Frame: Infant age 12 months ]
    Infant social-emotional development will be assessed through maternal report on the Ages and Stages Questionnaire: Social-Emotional.

  56. Infant social-emotional problems [ Time Frame: Infant age 12 months ]
    Infant social-emotional problems will be assessed through maternal report on the Brief Infant-Toddler Social Emotional Assessment.

  57. Maternal self-efficacy [ Time Frame: Pre-intervention (third trimester of gestation or up to one month postpartum) ]
    Mothers will report on their parenting self-efficacy using the Maternal Self-Efficacy Scale. Mothers will rate their self-efficacy for each of ten items (nine discrete parenting behaviors and one global parenting item) on a 4-point scale from 1-not good at all to 4-very good. Scores are summed to form a total maternal self-efficacy composite (possible range = 10-40), where higher scores indicated more maternal self-efficacy.

  58. Maternal self-efficacy [ Time Frame: Infant age 12 months ]
    Mothers will report on their parenting self-efficacy using the Maternal Self-Efficacy Scale. Mothers will rate their self-efficacy for each of ten items (nine discrete parenting behaviors and one global parenting item) on a 4-point scale from 1-not good at all to 4-very good. Scores are summed to form a total maternal self-efficacy composite (possible range = 10-40), where higher scores indicated more maternal self-efficacy.

  59. Maternal emotion regulation [ Time Frame: Pre-intervention (third trimester of gestation or up to one month postpartum) ]
    Mothers will report on their emotion regulation using the Difficulties with Emotion Regulation Scale - Short Form (DERS-SF). The DERS-SF consists of 18 items rated on a scale from 1-almost never to 5-almost always. The DERS-SF yields six subscales (strategies, non-acceptance, impulse, goals, awareness, and clarity), each of which range from 3 to 15, and one total score, which ranges from 18 to 90. Higher scores indicate greater emotion dysregulation.

  60. Maternal emotion regulation [ Time Frame: Infant age 12 months ]
    Mothers will report on their emotion regulation using the Difficulties with Emotion Regulation Scale - Short Form (DERS-SF). The DERS-SF consists of 18 items rated on a scale from 1-almost never to 5-almost always. The DERS-SF yields six subscales (strategies, non-acceptance, impulse, goals, awareness, and clarity), each of which range from 3 to 15, and one total score, which ranges from 18 to 90. Higher scores indicate greater emotion dysregulation.


Secondary Outcome Measures :
  1. Maternal substance use - interview [ Time Frame: Pre-intervention (third trimester of gestation or up to one month postpartum) ]
    The Timeline Followback Interview will be used to assess maternal use of opioids, tobacco, alcohol, marijuana, and other substances.

  2. Maternal substance use - interview [ Time Frame: Infant age 6 months ]
    The Timeline Followback Interview will be used to assess maternal use of opioids, tobacco, alcohol, marijuana, and other substances.

  3. Maternal substance use - interview [ Time Frame: Infant age 12 months ]
    The Timeline Followback Interview will be used to assess maternal use of opioids, tobacco, alcohol, marijuana, and other substances.

  4. Maternal substance use - questionnaire [ Time Frame: Pre-intervention (third trimester of gestation or up to one month postpartum) ]
    Mothers will report their history of substance use using the NIDA ASSIST questionnaire.

  5. Maternal substance use - questionnaire [ Time Frame: Infant age 3 months ]
    Mothers will report recent substance use using the NIDA Quick Screen questionnaire.

  6. Maternal substance use - questionnaire [ Time Frame: Infant age 6 months ]
    Mothers will report recent substance use using the NIDA Quick Screen questionnaire.

  7. Maternal substance use - questionnaire [ Time Frame: Infant age 12 months ]
    Mothers will report recent substance use using the NIDA Quick Screen questionnaire.

  8. Maternal depressive symptoms [ Time Frame: Pre-intervention (third trimester of gestation or up to one month postpartum) ]
    Maternal depressive symptoms will be self-reported using the Beck Depression Inventory.

  9. Maternal depressive symptoms [ Time Frame: Infant age 3 months ]
    Maternal depressive symptoms will be self-reported using the Beck Depression Inventory.

  10. Maternal depressive symptoms [ Time Frame: Infant age 6 months ]
    Maternal depressive symptoms will be self-reported using the Beck Depression Inventory.

  11. Maternal depressive symptoms [ Time Frame: Infant age 12 months ]
    Maternal depressive symptoms will be self-reported using the Beck Depression Inventory.

  12. Infant physical growth [ Time Frame: Infant age 3 months ]
    Infant physical growth will be assessed using weight, length, and head circumference.

  13. Infant physical growth [ Time Frame: Infant age 6 months ]
    Infant physical growth will be assessed using weight, length, and head circumference.

  14. Infant physical growth [ Time Frame: Infant age 12 months ]
    Infant physical growth will be assessed using weight, length, and head circumference.

  15. Maternal experiences during labor and delivery [ Time Frame: Infant age 3 months ]
    Mothers will report on their experiences during labor and delivery using the Birth Satisfaction Scale-Revised questionnaire (BSS-R). This measure consists of ten items rated on a 5-point scale from 1-Strongly Disagree to 5-Strongly Agree. The total score ranges from 10-50, where higher scores represent more birth satisfaction.

  16. Home environment [ Time Frame: Infant age 3 months ]
    The home environment will be assessed using the Cognitive Stimulation subscale of the HOME Short Form, a combination of observation (two items) and maternal report (seven items). Observation items are binary (yes/no), and mother-report items are rated on a Likert-type scale and dichotomized. Dichotomous items are summed to form a total score (range 0-9), with higher scores indicating more cognitive stimulation.

  17. Maternal reward responsiveness [ Time Frame: Pre-intervention (third trimester of gestation or up to one month postpartum) ]
    Mothers will report their reward responsiveness using the Reward Responsiveness Scale. This is an 8-item scale rated on a 4-point scale from 1-Strong Disagreement to 4-Strong Agreement. The total score ranges from 8 to 32, with higher scores representing greater reward responsiveness.

  18. Maternal reward responsiveness [ Time Frame: Infant age 12 months ]
    Mothers will report their reward responsiveness using the Reward Responsiveness Scale. This is an 8-item scale rated on a 4-point scale from 1-Strong Disagreement to 4-Strong Agreement. The total score ranges from 8 to 32, with higher scores representing greater reward responsiveness.

  19. Maternal sleep [ Time Frame: Pre-intervention (third trimester of gestation or up to one month postpartum) ]
    Mothers will report on their sleep habits using the Pittsburgh Sleep Quality Index.

  20. Maternal sleep [ Time Frame: Infant age 3 months ]
    Mothers will report on their sleep habits using the Pittsburgh Sleep Quality Index.

  21. Maternal sleep [ Time Frame: Infant age 6 months ]
    Mothers will report on their sleep habits using the Pittsburgh Sleep Quality Index.

  22. Maternal sleep [ Time Frame: Infant age 12 months ]
    Mothers will report on their sleep habits using the Pittsburgh Sleep Quality Index.

  23. Infant sleep [ Time Frame: Infant age 3 months ]
    Mothers will report on their infant's sleep habits using the Brief Infant Sleep Questionnaire.

  24. Infant sleep [ Time Frame: Infant age 6 months ]
    Mothers will report on their infant's sleep habits using the Brief Infant Sleep Questionnaire.

  25. Infant sleep [ Time Frame: Infant age 12 months ]
    Mothers will report on their infant's sleep habits using the Brief Infant Sleep Questionnaire.

  26. SEEK Resource Use [ Time Frame: Infant age 3 months ]
    Mothers will report on their experiences with the SEEK intervention using the SEEK Resources Follow-up Interview.

  27. SEEK Resource Use [ Time Frame: Infant age 6 months ]
    Mothers will report on their experiences with the SEEK intervention using the SEEK Resources Follow-up Interview.

  28. Psychosocial challenges [ Time Frame: Infant age one month ]
    In the course of the SEEK intervention, mothers will complete the SEEK Parent Questionnaire, a screening questionnaire of common psychosocial challenges impacting parents of young children.

  29. Psychosocial challenges [ Time Frame: Infant age 12 months ]
    Mothers will complete the SEEK Parent Questionnaire, a screening questionnaire of common psychosocial challenges impacting parents of young children.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • In third trimester of pregnancy or up to one month postpartum
  • Receiving medication-assisted treatment for opioid use disorder

Exclusion Criteria:

  • None

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03891628


Contacts
Layout table for location contacts
Contact: Madelyn Labella, PhD 302-232-5170 mlabella@psych.udel.edu

Locations
Layout table for location information
United States, Delaware
University of Delaware Recruiting
Newark, Delaware, United States, 19716
Contact: Madelyn Labella, PhD    302-232-5170    mlabella@psych.udel.edu   
Principal Investigator: Mary Dozier, PhD         
Sponsors and Collaborators
University of Delaware
Layout table for additonal information
Responsible Party: Mary Dozier, Amy E. du Pont Chair of Child Development, University of Delaware
ClinicalTrials.gov Identifier: NCT03891628    
Other Study ID Numbers: PSYC412125
First Posted: March 27, 2019    Key Record Dates
Last Update Posted: June 30, 2020
Last Verified: June 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Opioid-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders